Arachidonylcyclopropylamide
Arachidonylcyclopropylamide (ACPA) is a synthetic agonist of the cannabinoid receptor 1 (CB1R). ACPA is considered to be a selective cannabinoid agonist as it binds primarily to the CB1R and has low affinity to the cannabinoid receptor 2 (CB2R) (Ki = 2.2 nM for CB1R; Ki = 700 nM for CB2R).[1]
![]()  | |
| Names | |
|---|---|
| Preferred IUPAC name
 (5Z,8Z,11Z,14Z)-N-(Cyclopropyl)icosa-5,8,11,14-tetraenamide  | |
| Other names
 ACPA  | |
| Identifiers | |
3D model (JSmol)  | 
|
| ChEMBL | |
| ChemSpider | |
PubChem CID  | 
|
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C23H37NO | |
| Molar mass | 343.555 g·mol−1 | 
| Solubility in other solvents | soluble in ethanol, chloroform, THF and DMSO | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
References
    
    
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
